CClinicalTrials.gg
Status unknownNCT02545686CPAP_normalUpdated Oct 27, 2017

Effect of CPAP on Breath Hold and Chest Movement in Normal Volunteers

An interventional study of Chest wall movement assessment without CPAP and Breath hold assessment without CPAP in Healthy Volunteers and Effect of CPAP on Chest Movement, sponsored by Sheba Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-27.

Sponsored by Sheba Medical Center · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Study summary

CPAP will be applied to normal volunteers inorder to understand CPAP's effects on breathing and chest wall motion.

Read the detailed description

CPAP is a non-invasive ventilation technique that is commonly used to treat sleep apnea. Using a small air-pump, tubing and facemask, it provides a constant stream of pressurized air to the upper airways and lungs. Some of the physiological effects noted during CPAP are hyperinflation of the lungs, stabilizing and flattening of the diaphragm, and decrease in tidal volume. The effects on duration of breath hold are unknown. During radiation treatment, these effects are expected to reduce tumor and organ motion which reduces the volume of normal tissue being irradiated and also creates favorable treatment geometry by moving the heart away from the anterior chest wall. An important advantage of CPAP compared to other techniques is that active patient cooperation is not required. The potential exists to combine use of CPAP with other respiratory management techniques such as breath hold and improve overall effectiveness. When used in sleep apnea it is well tolerated and poses little risk to patients. There are no published reports of the use of CPAP in radiation therapy.

In initial studies the Varian RPM system was used to assess respiratory motion with and without CPAP for patients receiving radiation therapy. This commercially available, non-invasive system works by directing an infrared beam onto an infrared motion detector that is placed on the patients' upper abdomen. The detector records the change in abdomen position that occurs with respiration as a change in amplitude of the detector position. Interventions that effect respiration will be recorded by an increase or decrease in the amplitude of the detector motion. When used in breath hold, the detector remains in a fixed position with a very narrow gating window.

Based on initial experience with the RPM system, it has been found that approximately 1 hour of CPAP use is required to reduce diaphragm motion. Although early results are favorable using this approach, it is not certain that this is the best or most efficient method of use for all patients. The use of CPAP combined with breath hold techniques has not been studied.

The objectives of this study are to use the RPM system in normal volunteers to:

  1. Study the effects of CPAP on diaphragm motion to allow better optimization for the use of CPAP as a respiratory management technique during free breathing.
  2. Determine the feasibility of use of CPAP as a respiratory aid for use in patients treated with breath hold techniques. Determine the effects of CPAP on duration; reproducibility and tolerance of the breath hold technique.
02

Conditions studied

  • Healthy Volunteers
  • Effect of CPAP on Chest Movement
03

In context

Lead sponsor

Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Normal volunteers without a cancer diagnosis.
  • No contraindications to the use of CPAP

    • Facial injury or deformity preventing wearing facial mask
    • Recurrent vomiting
    • Chronic cough with phlegm
    • Previous pneumothorax
    • Facial lacerations or fractures
    • Recent tracheal or esophageal anastomosis
    • Recent GI surgery (last 90 days).
  • 18-90 years of age
  • Ability to sign informed consent
  • Hebrew or English speakers

Exclusion criteria

Exclusion Criteria:

  • Contraindications to CPAP

    • Facial injury or deformity preventing wearing facial mask
    • Recurrent vomiting
    • Chronic cough with phlegm
    • Previous pneumothorax
    • Facial lacerations or fractures
    • Recent tracheal or esophageal anastomosis
    • Recent GI surgery (last 90 days).
  • Under age 18 or above age 90 years
  • Inability to sign informed consent
  • Members of special populations (mental illness, pregnant women, prisoners, not legally competent).
  • History of severe active restrictive or obstructive lung disease (as defined as at least one hospitalization over previous two years)
  • Any medical condition requiring an inpatient hospitalization for more than 72 hours over the previous 2 years, aside from elective surgery.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    one

    this is a single arm study. All subjects treated the same way, and undergo four interventions: 1. Chest wall movement assessment without CPAP 2. Breath hold assessment without CPAP 3. Chest wall movement assessment with CPAP 4. Breath hold assessment with CPAP

    Behavioral: Chest wall movement assessment without CPAP · Behavioral: Breath hold assessment without CPAP · Procedure: Chest wall movement assessment with CPAP · Procedure: Breath hold assessment with CPAP

Interventions

  • BehavioralChest wall movement assessment without CPAP

    While subject is breathing normally, determine chest wall movement (via RPM waveform) with free breathing, over the course of half an hour.

  • BehavioralBreath hold assessment without CPAP

    While subject is breathing normally, subject will perform a moderate and a deep inspiratory breath hold. Duration, reproducibility and tolerance of deep inspiratory breath hold will be recorded.

  • ProcedureChest wall movement assessment with CPAP

    While subject is breathing via CPAP machine, determine chest wall movement (via RPM waveform) with free breathing, over the course of half an hour.

  • ProcedureBreath hold assessment with CPAP

    While subject is breathing via CPAP machine, subject will perform a moderate and a deep inspiratory breath hold. Duration, reproducibility and tolerance of deep inspiratory breath hold will be recorded.

06

What researchers measure

Primary outcomes

  1. Chest wall motion amplitude

    Amplitude of chest wall motion, measured in centimeters.

    Time frame: 2 hours

Secondary outcomes

  1. Duration of breath hold

    Length (in seconds) that are subjects able to hold their breath.

    Time frame: 2 hours

  2. Reproducibility of breath hold depth

    When 'breath hold' is performed three consecutive times, ascertain if it performed to the same depth each time. Measured in centimeters.

    Time frame: 2 hours

  3. Respiratory rate

    Number of breaths per minute.

    Time frame: 2 hours

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 27, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02545686
Lead sponsor
Sheba Medical Center
Responsible party
Sponsor
First posted
Sep 10, 2015
Start date
Sep 2015
Primary completion
Sep 2018 (estimated)
Completion
Sep 2019 (estimated)
Last update
Oct 27, 2017

Study contacts

Hila Gnessin
Contact
Hila.Gnessin@sheba.health.gov.il
972-3-5307340
Eve Keret
Contact
Eve.Keret@sheba.health.gov.il
972-3-5303207
Jeffrey Goldstein, MD
principal investigator · Sheba Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion